Searched for
GLAXOSMITHKLINE LOSS
Two Trades for Today: A water technology solutions firm for over 7% rise, a pharma stock for over 8.5% gainTechnical analysis identifies select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.- Stocks in the news: YES Bank, Airtel, GE T&D India, JSW Steel, Adani Green and Voda IdeaVodafone Idea will drop brand name "Idea" from its postpaid services.
- Even moat does not last long; buy if you find it, but stay alert of changesA business with a moat would imply one which has higher earnings power & higher margins.
- Market Movers: Icra warns of higher CAD, manufacturing improves & oil prices up on output cut hopesA look at top macro triggers that may move market on Tuesday.
- Stocks in focus on May 14, 2018Here is a list of top stocks that are likely to be in focus in today's trading session:
- Nestle speeds up its game to touch double digit growthNestle has decided to reduce processes across functions by 30-40 per cent, reduce meetings by 50 per cent to speed up internal decision mak...
- Nestle says back in market-leading slot after Maggi relaunchNestle India claimed a 57% market share for the flagship Maggi brand while announcing its second quarter earnings late last month.
- Buy GlaxosmithKline Consumer Healthcare with a target of Rs 6,430: Sandeep Wagle"GlaxosmithKline Consumer Healthcare is a 'BUY' call with a target of Rs 6,430 and a stop loss of Rs 6,070. "
- Sensex rallies 400 points, Nifty tests 8300, HUL slumps 3%; top 10 stocks in focusThe rally in the index was led by gains in ICICI Bank, HDFC, Tata Motors, Sun Pharma, L&T and Reliance Industries Ltd.
- Buy Glaxo SmithKline with a target of Rs 2750: Mitesh Thacker'Glaxo SmithKline is a 'BUY' call with a target of Rs 2750 and a stop loss of Rs 2620.'
- 'BUY' or 'SELL' ideas from experts for Thursday, 25 September 2014ET Now spoke to various experts and here's what they have to recommend for today's trade.
- ET analysis: Will Unilever's offer to raise stake in HUL mark the start of the end of equity cultureUnilever's decision to raise its stake in HUL may be a reflection of its desperation to grab a higher share of the India growth story.
- Budget 2013: OPPI seeks amendment in Specified Domestic TransactionsOPPI has proposed that Budget 2013 should amend Specified Domestic Transactions. The proposed amendment seeks to cover a situation wherein ...
- Buy GlaxoSmithKline Pharmaceuticals with a target of 2350: Ashwani GujralGlaxoSmithKline Pharmaceuticals Ltd is a ‘BUY’ call with a target of Rs 2350 and a stop loss of Rs 2200.
- Unfair practices: Pharma cos GlaxoSmithkline, Pfizer, Johnson & Johnson and others fined $13 bn in 4 yearsGlaxoSmithkline, Pfizer, Johnson & Johnson, AstraZeneca, Merck, Abbot, Eli Lilly and Allergen have paid about $13 billion in fines to settl...
- Chart Check from Angel Broking for Tuesday, March 20: Glaxo, ArvindWe have compiled technical recommendations from Shardul Kulkarni, Senior Technical Analyst, Angel Broking for 1-2 weeks.
- GlaxoSmithKline Q1 net profit down at Rs 46 lakhGlaxoSmithkline Pharmaceuticals posted a massive decline in its net profit at Rs 46 lakh in the quarter ended March 31, from Rs 161 crore r...
- GlaxoSmithKline reports quarterly lossBritish drugs firm GlaxoSmithKline on Thursday posted a net loss of £690 mn (813 mn euros, $1.119 bn) for the fourth quarter of 2010 on the...
- Buy Glaxo Smithkline Pharma for target of Rs 2160: APTARTBuy the stock in the range of Rs 2070-2050 with stoploss of Rs 2035 for target of Rs 2160. Price and volume breakout seen in the stock, say...
- MNC advertisers have reason to cheerThe ITAT said that the expenses on advertisements can be deducted to arrive at the taxable income.
Load More
